Effects of leukotrienes on osteoblastic cell proliferation
- PMID: 1657327
- DOI: 10.1007/BF02556118
Effects of leukotrienes on osteoblastic cell proliferation
Abstract
Leukotriene B4 (LTB4) is an arachidonic acid lipoxygenase metabolite with well-characterized effects on leukocytes. LTB4 has been implicated in acute inflammatory reactions and in bone resorption. In the present study, the effect of LTB4 on osteoblastic cells was examined. LTB4 inhibited cell proliferation in normal osteoblastic rat calvaria cells in a dose-dependent manner and had biphasic effects in the human osteoblast-like osteosarcoma cell lines Saos-2 and G292. Indomethacin did not modulate the nature of these LTB4 effects in any of the cells. However, it potentiated the high LTB4 dose effects in normal cells and G292 cells. AA861, an inhibitor of lipoxygenase, did not modulate the LTB4 effects in these two cell lines. These results suggest that LTB4 is involved in the regulation of osteoblastic cell proliferation and may interact with prostaglandins to modulate these effects.
Similar articles
-
Regulation of C-myc protooncogene expression in osteoblastic cells by arachidonic acid metabolites: relationship to proliferation.Calcif Tissue Int. 1992 Apr;50(4):372-7. doi: 10.1007/BF00301636. Calcif Tissue Int. 1992. PMID: 1315190
-
Effects of a 5-lipoxygenase inhibitor, AA861, on lipoxygenase metabolism and superoxide anion generation by human polymorphonuclear leukocytes--potentiation of superoxide anion generation by LTB4.Int Arch Allergy Immunol. 1992;98(4):361-9. doi: 10.1159/000236212. Int Arch Allergy Immunol. 1992. PMID: 1330136
-
Involvement of leukotriene B4 in zymosan-induced rat pleurisy: inhibition of leukocyte infiltration by the 5-lipoxygenase inhibitor T-0757.Biol Pharm Bull. 1995 Sep;18(9):1302-4. doi: 10.1248/bpb.18.1302. Biol Pharm Bull. 1995. PMID: 8845830
-
Prostaglandins and leukotriene B4 are potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cells.Biol Reprod. 1999 Jul;61(1):40-5. doi: 10.1095/biolreprod61.1.40. Biol Reprod. 1999. PMID: 10377029
-
5-Lipoxygenase metabolites inhibit bone formation in vitro.Endocrinology. 1998 Jul;139(7):3178-84. doi: 10.1210/endo.139.7.6115. Endocrinology. 1998. PMID: 9645691
Cited by
-
Fracture healing and lipid mediators.Bonekey Rep. 2014 Apr 2;3:517. doi: 10.1038/bonekey.2014.12. eCollection 2014. Bonekey Rep. 2014. PMID: 24795811 Free PMC article. Review.
-
Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice.Metabolism. 2016 Sep;65(9):1247-58. doi: 10.1016/j.metabol.2016.05.007. Epub 2016 May 19. Metabolism. 2016. PMID: 27506732 Free PMC article.
-
Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study.Endocrinol Metab (Seoul). 2025 Feb;40(1):82-92. doi: 10.3803/EnM.2024.1990. Epub 2024 Aug 30. Endocrinol Metab (Seoul). 2025. PMID: 39212038 Free PMC article.
-
Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.Bone. 2007 Jul;41(1):68-76. doi: 10.1016/j.bone.2007.03.009. Epub 2007 Mar 21. Bone. 2007. PMID: 17467356 Free PMC article.
-
Leukotriene B4 loaded in microspheres regulate the expression of genes related to odontoblastic differentiation and biomineralization by dental pulp stem cells.BMC Oral Health. 2022 Feb 23;22(1):45. doi: 10.1186/s12903-022-02083-8. BMC Oral Health. 2022. PMID: 35197043 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources